← Leaderboards
Michael A Burke
Emory University
$2,526,117
Attributed
$2,526,117
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $434.2K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,526,117 · 2
By mechanism
R01$1,722,057 · 1
K08$804,060 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Jeff M Sands$14,564,095
- Andrew B Adams$22,168,263
- Gregory B. Lesinski$9,344,242
- Mehmet Akce$196,628
Others in their field
Other Emerging Leaders on “Gene Expression”
- Evan Z Macosko · Broad Institute, Inc.$35,121,158
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Benjamin E Deverman · Broad Institute, Inc.$16,920,984
- Tomasz Nowakowski · University Of California, San Francisco$15,628,426
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Crystal Mackall · Children'S Hosp Of Philadelphia$14,040,300
Research focus
Gene ExpressionInsightDilated CardiomyopathyFutureGenetic ModelsInnovationCardiovascular SystemClinical ResearchExperimental StudyFibrosisAffectGenesHeartHeart FailureCardiologyCardiovascular DiseasesCell CompartmentationCessation Of LifeCalciumEchocardiographyCardiacFibroblastsCardiac MyocytesLeft
Grant awards (9)
Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure$434,172
R01 · FY2025 · HL · contact PI
Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure$425,488
R01 · FY2024 · HL · contact PI
Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure$434,172
R01 · FY2023 · HL · contact PI
Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure$428,225
R01 · FY2022 · HL · contact PI
Epigenetic control of pathologic cardiac remodeling$160,812
K08 · FY2021 · HL · contact PI
Epigenetic control of pathologic cardiac remodeling$160,812
K08 · FY2020 · HL · contact PI
Epigenetic control of pathologic cardiac remodeling$160,812
K08 · FY2019 · HL · contact PI
Epigenetic control of pathologic cardiac remodeling$160,812
K08 · FY2018 · HL · contact PI
Epigenetic control of pathologic cardiac remodeling$160,812
K08 · FY2017 · HL · contact PI